143 related articles for article (PubMed ID: 10430402)
1. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
[TBL] [Abstract][Full Text] [Related]
2. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
[TBL] [Abstract][Full Text] [Related]
3. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Casaldi V; Cavaliere F; Carlini M; Garofalo A; Rinaldi G
Anticancer Res; 1993; 13(6B):2409-13. PubMed ID: 8135475
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
Spila A; Roselli M; Cosimelli M; Ferroni P; Cavaliere F; Arcuri R; Tedesco M; Carlini S; D'Alessandro R; Perri P; Casciani CU; Greiner JW; Schlom J; Guadagni F
Anticancer Res; 1996; 16(4B):2241-7. PubMed ID: 8694550
[TBL] [Abstract][Full Text] [Related]
6. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients].
Tabuchi Y; Deguchi H; Saitoh Y
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1181-91. PubMed ID: 3185486
[TBL] [Abstract][Full Text] [Related]
7. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma.
Ikeguchi M; Katano K; Saitou H; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1997; 44(15):866-71. PubMed ID: 9222706
[TBL] [Abstract][Full Text] [Related]
9. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
[TBL] [Abstract][Full Text] [Related]
10. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
Deguchi H; Tabuchi Y; Saitoh Y
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
[TBL] [Abstract][Full Text] [Related]
11. [Histopathologic and immunohistochemical studies on the elevation mechanism of carcinoembryonic antigen (CEA) in gastric cancer patients].
Imanishi K; Tabuchi Y; Saitoh Y
Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):843-51. PubMed ID: 3185471
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
[TBL] [Abstract][Full Text] [Related]
13. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
[TBL] [Abstract][Full Text] [Related]
14. Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
Takahashi I; Maehara Y; Kusumoto T; Kohnoe S; Kakeji Y; Baba H; Sugimachi K
Br J Cancer; 1994 Jan; 69(1):163-6. PubMed ID: 8286201
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.
Kodera Y; Yamamura Y; Torii A; Uesaka K; Hirai T; Yasui K; Morimoto T; Kato T; Kito T
Am J Gastroenterol; 1996 Jan; 91(1):49-53. PubMed ID: 8561143
[TBL] [Abstract][Full Text] [Related]
16. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
[TBL] [Abstract][Full Text] [Related]
17. [Patients with high risk of hematogenous metastasis and recurrence in colorectal cancer: correlation with histopathologic variables and tumor markers, CEA and CA19-9, in peripheral and draining venous blood].
Deguchi H; Tabuchi Y; Saitoh Y
Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):664-71. PubMed ID: 1886571
[TBL] [Abstract][Full Text] [Related]
18. [The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer].
Imamura Y; Yasutake K; Yoshimura Y; Oya M; Matsushita K; Tokisue M; Ohno S; Masuda T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1501-7. PubMed ID: 2143888
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative serum levels of CEA and CA19-9 in patients with gastric cancer].
Roviello F; Garosi L; Marrelli D; De Stefano A; Udhris C; Messano A; Pinto E
Minerva Chir; 1996 Mar; 51(3):133-9. PubMed ID: 8684652
[TBL] [Abstract][Full Text] [Related]
20. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
